The discrepancy between slower proliferation of shPHD3 tumor cells in vitro and faster growth rates in vivo suggests a pivotal contribution of the tumor microenvironment in the growth acceleration of PHD3-deficient tumors. The gene discussed is EGLN3; the disease is neoplasm.